Eidos Therapeutics
Why Robinhood?
You can watch EIDX and buy or sell other stocks, ETFs, and their options commission-free!About EIDX
Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR.
EIDX Key Statistics
Stock Snapshot
As of today, Eidos Therapeutics(EIDX) shares are valued at $122.21. The company's market cap stands at 4.75B, with a P/E ratio of -46.10.
On 2026-05-15, Eidos Therapeutics(EIDX) stock opened at —, reached a high of —, and a low of —.
The Eidos Therapeutics(EIDX)'s current trading volume is 0, compared to an average daily volume of 138.46K.
In the last year, Eidos Therapeutics(EIDX) shares hit a 52-week high of $132.54 and a 52-week low of $28.39.
In the last year, Eidos Therapeutics(EIDX) shares hit a 52-week high of $132.54 and a 52-week low of $28.39.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.